As part of the “Bringing innovation to the health tech market” event held on September 19th, in the presence of the Deputy Prime Minister, Minister of the Economy and Minister of Health, Étienne Schneider, a Memorandum of Understanding (MoU) was signed between Hanalytics Sàrl, Hôpitaux Robert Schuman and the radiologists of the institution, in piloting a radiological image analysis solution based on artificial intelligence called BioMind. Hanalytics Sàrl is the Luxembourg subsidiary of the Singapore group Hanalytics. Its establishment is the result of the work carried out by the Ministry of the Economy, the House of Entrepreneurship and Luxinnovation to help the company to develop in the European market.
The company quickly found its way into the local ecosystem for the adoption of BioMind, one of the world’s first CE-certified AI diagnostic support system for brain conditions, for the benefit of patients, physicians and the economy.
BioMind is jointly developed by world-renowned medical specialists and machine-learning experts. It uses deep learning technology to analyse neurological disorders such as brain tumours, vascular diseases and stroke conditions. This AI application can also be upgraded to analyse medical images of other body systems.